NDA Submitted for Novel Insomnia Treatment Lemborexant - Monthly Prescribing Reference https://t.co/mZ9vp6sOoA
— IDRO (@IDROOhio) January 16, 2019
from Twitter https://twitter.com/IDROOhio
January 15, 2019 at 02:12PM
Tuesday, January 15, 2019
NDA Submitted for Novel Insomnia Treatment Lemborexant - Monthly Prescribing Reference https://t.co/mZ9vp6sOoA
from Twitter https://twitter.com/IDROOhio
January 15, 2019 at 02:12PM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment